Breaking Biotech

009 - MDGL buyout rumors push stock higher!


Listen Later

Today I look at Madrigal's Phase 2 results and talk about competitors in the NASH space. I also talk about Tandem and how we can use competitors to compare value Follow me on twitter @matthewlepoire This is not investment advice. I am not liable for any trading decisions you have made.
...more
View all episodesView all episodes
Download on the App Store

Breaking BiotechBy Matthew Lepoire

  • 4.9
  • 4.9
  • 4.9
  • 4.9
  • 4.9

4.9

24 ratings